T. Collaborative

Comparative effectiveness of sotrovimab and molnupiravir for preventing severe COVID-19 outcomes in non-hospitalised patients on kidney replacement therapy: observational cohort study using the OpenSAFELY-UKRR linked platform and SRR database

M. Scanlon, H. Curtis, A. Mehrkar, 2022, medRxiv.

Comparative effectiveness of two- and three-dose schedules involving AZD1222 and BNT162b2 in people with kidney disease: a linked OpenSAFELY and UK Renal Registry cohort study

A. Mehrkar, B. Goldacre, D. Nitsch, 2022, medRxiv.